Puberty blockers ban for under-18s made indefinite in the UK

manchestereveningnews.co.uk:

The sale and supply of puberty-suppressing hormones to treat gender dysphoria will be banned indefinitely in the UK for under-18s.

The move follows independent expert advice, published by the Commission on Human Medicines (CHM), which states there is currently an ‘unacceptable safety risk in the continued prescription of puberty blockers to children’, the Government said.

Puberty blockers for the treatment of gender dysphoria and gender incongruence in under-18s were banned temporarily in May 2024 after the Cass Review found there was insufficient evidence to show they were safe.

Legislation was being updated on Wednesday to make the order indefinite and it will be reviewed in 2027. READ NEXT: Breast cancer can be spotted at earliest stages thanks to new blood test, scientists say The Cass Review, published in April 2024, was led by Hilary Cass, a retired consultant paediatrician, and dealt with gender services for children and young people, including those with gender dysphoria and those identifying as transgender in England.